India-based synthetic biology startup StrainX Bioworks has raised $13 million (approximately ₹124 crore) in a new funding round led by Prime Venture Partners and Leo Capital.ContentsMultiple Investors Participate in Funding RoundCompany Targets Global Synthetic Biology OpportunityStartup Focuses on Precision Fermentation TechnologyFermentation Technology Gains Momentum Beyond PharmaStrainX Tests Production at Industrial ScaleInvestors See Growth Potential in … Continue reading StrainX Bioworks raises $13 million in round led by Prime Venture Partners